Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hypoxia × inositol trispyrophosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Liver Neoplasms 1 Hypoxia 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1

Interventions

TH 302 2 pomalidomide 1 inositol trispyrophosphate 1 fluoromisonidazole 1 fludarabine 1 Tirapazamine 1 Injections 1 Ethiodized Oil 1 Dexamethasone 1 Cyclophosphamide 1 Bortezomib 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02528526 2015-08-19

OXY1A

University of Zurich

Phase 1/2 Unknown

Gastrointestinal

Hypoxia, Liver Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡